Market Watch: Autolus Therapeutics plc ADR (AUTL)’s Noteworthy Gain, Closing at 1.60

Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.

As of close of business last night, Autolus Therapeutics plc ADR’s stock clocked out at $1.60, up 11.11% from its previous closing price of $1.44. In other words, the price has increased by $11.11 from its previous closing price. On the day, 3.17 million shares were traded. AUTL stock price reached its highest trading level at $1.605 during the session, while it also had its lowest trading level at $1.455.

Ratios:

To gain a deeper understanding of AUTL’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 10.77 and its Current Ratio is at 10.84. In the meantime, Its Debt-to-Equity ratio is 0.70 whereas as Long-Term Debt/Eq ratio is at 0.69.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Goldman on November 18, 2024, Upgraded its rating to Buy and sets its target price to $7.60 from $7 previously.

On November 15, 2024, Redburn Atlantic Upgraded its rating to Buy which previously was Neutral but kept the price unchanged to $13.

On November 09, 2023, Deutsche Bank started tracking the stock assigning a Buy rating and target price of $10.Deutsche Bank initiated its Buy rating on November 09, 2023, with a $10 target price.

Insider Transactions:

Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Sep 16 ’24 when Martin Pule bought 698,741 shares for $4.23 per share.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AUTL now has a Market Capitalization of 425806400 and an Enterprise Value of 135012240. For the stock, the TTM Price-to-Sale (P/S) ratio is 42.07 while its Price-to-Book (P/B) ratio in mrq is 1.00. Its current Enterprise Value per Revenue stands at 13.341 whereas that against EBITDA is -0.579.

Stock Price History:

The Beta on a monthly basis for AUTL is 1.69, which has changed by -0.6199525 over the last 52 weeks, in comparison to a change of 0.042615533 over the same period for the S&P500. Over the past 52 weeks, AUTL has reached a high of $5.00, while it has fallen to a 52-week low of $1.11. The 50-Day Moving Average of the stock is -6.25%, while the 200-Day Moving Average is calculated to be -46.99%.

Shares Statistics:

It appears that AUTL traded 1.47M shares on average per day over the past three months and 2317400 shares per day over the past ten days. A total of 266.13M shares are outstanding, with a floating share count of 240.32M. Insiders hold about 9.70% of the company’s shares, while institutions hold 54.59% stake in the company. Shares short for AUTL as of 1743379200 were 9910212 with a Short Ratio of 6.76, compared to 1740700800 on 9104667. Therefore, it implies a Short% of Shares Outstanding of 9910212 and a Short% of Float of 4.9099997.

Dividends & Splits

Against a Trailing Annual Dividend Yield of 0.0

DWinneX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.